BioSpace - Print News Article

Anthera Pharmaceuticals, Inc. Plans $70 Million IPO 9/16/2009 8:59:59 AM Bizjournals.com -- A Hayward biotech focused on inflammatory diseases like from cardiovascular disease and lupus filed for one of the first U.S. biotech IPO in two years.

Anthera Pharmaceuticals, Inc. Plans $70 Million IPO
9/16/2009 8:59:59 AM

Bizjournals.com -- A Hayward biotech focused on inflammatory diseases like from cardiovascular disease and lupus filed for one of the first U.S. biotech IPO in two years.